Abstract:The recent FDA approval of VOQUEZNATM TRIPLE PAKTM 7-day therapy, which includes vonoprazan (VON), amoxicillin (AMO), and clarithromycin (CLA), marks a significant advancement in the treatment of Helicobacter pylori ( H. pylori ) infections. Accurate quantification of these active pharmaceutical ingredients (APIs) is critical for ensuring therapeutic efficacy and safety. However, conventional analytical methods often require extensive sample pretreatment and separation, which can be time-consuming and environmentally burdensome. This study presents the first simultaneous quantification of VON, AMO, and CLA using innovative chemometric-assisted spectrophotometric methods aligned with Green Analytical Chemistry (GAC) principles. Our methods eliminate the need for pretreatment or separation, thereby enhancing both analytical efficiency and environmental sustainability. We developed orthogonal partial least squares (OPLS), principal component regression (PCR), and Artificial Neural Network (ANN) models, utilizing the Design of Experiment (DoE) approach to minimize solvent use and waste.Model validation was achieved through Orthogonal Array-based Latin Hypercube Sampling (OALHS), ensuring robust performance evaluation. The models demonstrated high precision, with recovery percentages ranging from 98.00% to 102.00%. The calibration set model fitting was assessed using the determination coefficient (R 2 ), and the cross-validation coefficient (Q 2 ), all model's R 2 and Q 2 values were close to 1.0, indicating the calibration samples' high capacity for explanation and prediction, while the root mean square error of calibration (RMSEC) values were found to be less than 0.1. The prediction of the validation set was employed by the root mean square error of prediction (RMSEP) and relative root mean square errors of prediction (RRMSEP), the values were found (0.0335–0.0613) and (0.7207–0.5287) for RMSEP and RRMSEP, respectively, while the bias-corrected mean square error of prediction (BCMSEP) was found to be between 0.0014 and 0.0001. To evaluate and enhance the sustainability of the methods, comprehensive tools were utilized: SPIDER Solvent Tool, RGB12 Algorithm, AGREE, and the Need Quality Sustainability (NQS) Index. This work supports the Sustainable Development Goals (SDGs) by demonstrating advancements in environmentally sustainable analytical methods.

Determination of omeprazole via fluorescence‐quenching methodology; application to content uniformity testing

Plant extract mediated synthesis of ZnO and CeO2 nanoparticles for spectrofluorometric assay of omeprazole and domperidone in pharmaceuticals

Analytical quality by design-based development of a capillary electrophoresis method for Omeprazole impurity profiling

RELIABLE SPECTROSCOPIC ANALYTICAL PROCEDURE FOR QUANTITATIVE ESTIMATION OF OSIMERTINIB MESYLATE IN LIPOSOMAL DRY POWDER INHALER FORMULATION

Spectrophotometric determination of olanzapine, fluoxetine HCL and its impurity using univariate and chemometrics methods reinforced by latin hypercube sampling: Validation and eco-friendliness assessments

A facile on–off fluorescence approach for fluvoxamine determination in pharmaceutical tablets; application to content uniformity testing

Nitrogen and sulfur-doped carbon quantum dots as fluorescent nanoprobes for spectrofluorimetric determination of olanzapine and diazepam in biological fluids and dosage forms: application to content uniformity testing

Development and validation of a new spectrofluorimetric method for the determination of some beta-blockers through fluorescence quenching of eosin Y. Application to content uniformity test

Colorimetric Determination of Amoxicillin in Pure and some Pharmaceutical Formulations Via Reaction with Potassium Permanganate as Oxidant Reagent

HPLC-Fluorescence Detection Method for Concurrent Estimation of Domperidone and Naproxen. Validation and Eco-Friendliness Appraisal Studies

AQbD-enhanced green RP-UPLC-PDA methodology for quantification and forced degradation studies for omeprazole, amoxicillin, and rifabutin

New analytical LC–MS/MS method for fluconazole and ivermectin estimation in combined pharmaceutical dosage form: development and validation

Chemometric-assisted spectrophotometric methods for simultaneous drug determination in new Helicobacter pylori treatment regimens - Environmental sustainability assessment

Direct fluorescence and spectrophotometric-based detection of azithromycin using fluorescein isothiocyanate: Method development and comparative analysis

Exploiting the Diazotization Reaction of 8-hydroxyquinoline for Determination of Metoclopramide-hydrochloric acid in Pharmaceutical Preparations

A simple eco-friendly spectrofluorimetric resolution approach for the simultaneous determination of Naproxen and Domperidone in pharmaceutical formulation and human plasma; assessment of method greenness

Spectrofluorimetric Determination of Fluvoxamine in Dosage Forms and Plasma Via Derivatization with 4-Chloro-7-Nitrobenzo-2-Oxa-1,3-Diazole

A new spectrophotometric method for the quantitative determination of Metopimazine based on the absorbance of its sulfoxide

Validated chromatographic approach for determination of two ternary mixtures in newly approved formulations for helicobacter pylori eradication: assessment of greenness profile and content uniformity

Determination of Fluorinated Quinolone Antibacterials by Ion Chromatography with Fluorescence Detection.

A green micelle‐enhanced first derivative synchronous fluorescence approach for determination of donepezil HCl and trazodone HCl in their pure state, pharmaceutical dosage form and spiked human plasma